ImmunoCellular Therapeutics (IMUC) Cash flow

186 Followers

ImmunoCellular Therapeutics Cash Flow

IMUC's free cash flow for Q4 2022 was $-687.93K. For the 2022 fiscal year, IMUC's free cash flow was decreased by $1.19M and operating cash flow was $-687.93K. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Operating Cash Flow	$ -1.49M	$ -2.68M	$ -1.42M	$ -2.62M	$ -2.31M
Investing Cash Flow	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Financing Cash Flow	$ 1.43M	$ 2.50M	$ 1.09M	$ 1.75M	$ 3.53M
End Cash Position	$ 29.76K	$ 98.67K	$ 278.26K	$ 613.24K	$ 1.49M
Free Cash Flow	$ -1.49M	$ -2.68M	$ -1.42M	$ -2.62M	$ -2.31M

Currency in USD